NICE publishes guidance recommending Bayer’s Kerendia® (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes
March 23, 2023Business Services
Reading, 23rd March 2023 – Today, the National Institute for Health and Care Excellence (NICE) has published a new guidance …
SYMBICORT (budesonide/formoterol) TURBOHALER 200/6 APPROVED AS FIRST AND ONLY COMBINATION RELIEVER FOR MILD ASTHMA IN THE UK
March 23, 2023Business Services
London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …
BIAL appoints Max Bricchi as Chief Commercial Officer
March 23, 2023Business Services
BIAL has announced the appointment of Max Bricchi as Chief Commercial Officer (CCO) and Executive Board member. With responsibility for …
Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting
March 23, 2023Business Services
Tokyo, Japan and Cambridge, UK, 23 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m
March 23, 2023Sales and Marketing
Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …
Biogen shares FDA decisions on ALS drug
March 23, 2023Research and Development
US-based Biogen has announced two decisions the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee made surrounding its ALS …
Incyte has announced FDA approval of Zynyz
March 23, 2023Medical Communications
Incyte has today announced that the FDA gas approved Zynyz (retifanlimab-dlwr) for the treatment of adult patients with metastatic or …
India cancels manufacturing licence for Marion Biotech after cough syrup deaths
March 23, 2023Medical Communications
Uttar Pradesh, a state in India, has cancelled the manufacturing licence of Marion Biotech after two cough syrups made at …
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
March 22, 2023Business Services
VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have …
Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data
March 22, 2023Business Services
Boston, March 22, 2023 — YonaLink, a clinical trial software provider, today announced its EHR-to-EDC data integration platform has been …
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
March 22, 2023Business Services
HERCULES, Calif. — March 15, 2023 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science …
InvoX Pharma’s F-star announces licence agreement with Takeda for second novel next-generation immuno-oncology bispecific antibody
March 22, 2023Business Services
LONDON, United Kingdom, March, 22, 2023 (GLOBE NEWSWIRE): InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited …
Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression
March 22, 2023Business Services
Boston, Massachusetts March 22, 2023 – Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify …
ELLAB LAUNCHES NEW MONITORING SOLUTION FOR LIFE-SAVING PRODUCTS
March 22, 2023Business Services
Ellab has launched a new continuous monitoring solution for the biotech and pharmaceutical sectors, which accurately monitors critical processes 24/7. …
CANARY WHARF ATTRACTS LIFE SCIENCES FOCUSED STARTUPS AND SCALEUPS TO ITS TECHNOLOGY COMMUNITY AT LEVEL39
March 22, 2023Business Services
22 March 2023: The development of a major life science cluster at Canary Wharf continues to build momentum with a …
Sequana Medical announces additional patents for DSR® in China and the United States
March 22, 2023Business Services
Ghent, Belgium – 22 March 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana
Roche and Eli Lilly collaborate on Alzheimer’s disease blood test
March 22, 2023Medical Communications
Swiss biotech company Roche has announced a collaboration with US pharmaceutical company Eli Lilly to develop Roche’s Elecsys Amyloid Plasma …
Kite’s Yescarta CAR T-cell therapy shows statistically significant improvement in overall survival
March 22, 2023Research and Development
Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment …
Promising ovarian cancer drug enters phase 3 trial
March 22, 2023A new drug to treat ovarian cancer is set to enter the phase 3 UP-NEXT trial imminently. Upifitamab rilsodotin is …
Faron Pharmaceuticals announces positive FDA feedback for solid tumour therapy
March 22, 2023Research and Development
Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for solid tumour …
Latest content
FibroFind appoints Lee Borthwick as CEO
